Iron Deficiency Guidance Varies in Premenopausal Women

A Beyond the Guidelines discussion highlighted uncertainty around gastrointestinal evaluation and intravenous iron use in premenopausal women with iron deficiency.

By
Andrea Surnit
June 11, 2026
5 min

MDSpire News

At a Glance

Category	Detail
Condition	Iron Deficiency in Premenopausal Women
Key Mechanisms	Heavy menstrual bleeding, microcytosis, and low ferritin levels.
Target Population	Premenopausal women with iron deficiency.
Care Setting	Clinical practice, particularly in gynecology and gastroenterology.

Key Highlights

Iron deficiency may require treatment even without meeting anemia thresholds.
Ferritin is a key noninvasive marker for iron deficiency.
Bidirectional endoscopy is conditionally recommended for asymptomatic women with iron deficiency anemia.
Intravenous iron may be preferred in cases of ongoing blood loss.
Differing opinions exist on the necessity of gastrointestinal evaluation.

Guideline-Based Recommendations

Diagnosis

Use ferritin as a primary marker for iron deficiency.
Consider a Bayesian approach for diagnosis incorporating symptoms and lab results.

Management

Oral iron is recommended first for most patients without urgent needs.
Intravenous iron may be indicated for patients with heavy menstrual bleeding.

Monitoring & Follow-up

Repeat laboratory testing after 4 to 6 weeks of iron therapy.

Risks

Gastrointestinal evaluation may be overestimated in asymptomatic premenopausal women.

Patient & Prescribing Data

Premenopausal women with iron deficiency and heavy menstrual bleeding.

Consider intravenous iron for rapid repletion in cases of ongoing blood loss.

Clinical Best Practices

Maintain a low threshold for gastrointestinal evaluation when iron deficiency causes are unclear.
Differentiate between pseudoallergy and true hypersensitivity reactions to intravenous iron.